Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women

M Roustit, M Jlaiel, P Leclercq… - British journal of …, 2008 - Wiley Online Library
Highly active antiretroviral therapy is recommended for HIV‐infected pregnant women to
prevent mother‐to‐child transmission. The specific physiological background induced by …

Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women

M Roustit, M Jlaiel, P Leclercq… - British journal of …, 2008 - pubmed.ncbi.nlm.nih.gov
Highly active antiretroviral therapy is recommended for HIV-infected pregnant women to
prevent mother-to-child transmission. The specific physiological background induced by …

Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

M Roustit, M Jlaiel, P Leclercq, F Stanke-Labesque - 2008 - cabidigitallibrary.org
Highly active antiretroviral therapy is recommended for HIV-infected pregnant women to
prevent mother-to-child transmission. The specific physiological background induced by …

Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

M Roustit, M Jlaiel, P Leclercq… - British Journal of …, 2008 - search.ebscohost.com
Highly active antiretroviral therapy is recommended for HIV-infected pregnant women to
prevent mother-to-child transmission. The specific physiological background induced by …

[HTML][HTML] Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women

M Roustit, M Jlaiel, P Leclercq… - British Journal of …, 2008 - ncbi.nlm.nih.gov
Highly active antiretroviral therapy is recommended for HIV-infected pregnant women to
prevent mother-to-child transmission. The specific physiological background induced by …

Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

M Roustit, M Jlaiel, P Leclercq… - British Journal of …, 2008 - inserm.hal.science
Highly active antiretroviral therapy is recommended for HIV-infected pregnant women to
prevent mother-to-child transmission. The specific physiological background induced by …

Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

M Roustit, M Jlaiel, P Leclercq… - British Journal of Clinical …, 2008 - hal.science
Highly active antiretroviral therapy is recommended for HIV-infected pregnant women to
prevent mother-to-child transmission. The specific physiological background induced by …

[引用][C] Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women

M ROUSTIT, M JLAIEL, P LECLERCQ… - British journal of …, 2008 - pascal-francis.inist.fr
Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …

Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

M Roustit, M Jlaiel, P Leclercq… - British Journal of …, 2008 - europepmc.org
Highly active antiretroviral therapy is recommended for HIV-infected pregnant women to
prevent mother-to-child transmission. The specific physiological background induced by …

Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

M Roustit, M Jlaiel, P Leclercq… - British Journal of …, 2008 - europepmc.org
Highly active antiretroviral therapy is recommended for HIV-infected pregnant women to
prevent mother-to-child transmission. The specific physiological background induced by …